Akribion Genomics

Akribion Genomics develops gene-editing tools and cancer therapies using CRISPR nuclease technology.

Operating in biotechnology, health care, oncology based in European Union (EU), Europe, Middle East, and Africa (EMEA), Akribion Genomics operates.

Akribion Genomics is positioned in biotechnology, health care, oncology, a segment that rewards a clear, focused offering.

The business is associated with European Union (EU), Europe, Middle East, and Africa (EMEA).

The company is listed at the Private company stage of development.

Its team size is recorded as c_00011_00050 employees.

Sector	Biotechnology, Health Care, Oncology
Headquarters	European Union (EU), Europe, Middle East, and Africa (EMEA)
Country	DE
Employees	c_00011_00050
Stage	Private company

Website: www.akribion-genomics.com

Full contact details are available to registered Pixilab members.
Create a free account

Browse related